149 related articles for article (PubMed ID: 24759689)
1. Antimicrobial activity of pantothenol against staphylococci possessing a prokaryotic type II pantothenate kinase.
Chohnan S; Murase M; Kurikawa K; Higashi K; Ogata Y
Microbes Environ; 2014; 29(2):224-6. PubMed ID: 24759689
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections.
Choudhry AE; Mandichak TL; Broskey JP; Egolf RW; Kinsland C; Begley TP; Seefeld MA; Ku TW; Brown JR; Zalacain M; Ratnam K
Antimicrob Agents Chemother; 2003 Jun; 47(6):2051-5. PubMed ID: 12760898
[TBL] [Abstract][Full Text] [Related]
3. Feedback inhibition of pantothenate kinase regulates pantothenol uptake by the malaria parasite.
Lehane AM; Marchetti RV; Spry C; van Schalkwyk DA; Teng R; Kirk K; Saliba KJ
J Biol Chem; 2007 Aug; 282(35):25395-405. PubMed ID: 17581817
[TBL] [Abstract][Full Text] [Related]
4. How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis.
Kumar P; Chhibber M; Surolia A
Biochem Biophys Res Commun; 2007 Oct; 361(4):903-9. PubMed ID: 17679145
[TBL] [Abstract][Full Text] [Related]
5. Provitamin B5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite.
Saliba KJ; Ferru I; Kirk K
Antimicrob Agents Chemother; 2005 Feb; 49(2):632-7. PubMed ID: 15673744
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme A biosynthesis: an antimicrobial drug target.
Spry C; Kirk K; Saliba KJ
FEMS Microbiol Rev; 2008 Jan; 32(1):56-106. PubMed ID: 18173393
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
Thomas J; Cronan JE
Antimicrob Agents Chemother; 2010 Mar; 54(3):1374-7. PubMed ID: 20047918
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues.
Tjhin ET; Spry C; Sewell AL; Hoegl A; Barnard L; Sexton AE; Siddiqui G; Howieson VM; Maier AG; Creek DJ; Strauss E; Marquez R; Auclair K; Saliba KJ
PLoS Pathog; 2018 Apr; 14(4):e1006918. PubMed ID: 29614109
[TBL] [Abstract][Full Text] [Related]
9. Prokaryotic type III pantothenate kinase enhances coenzyme A biosynthesis in Escherichia coli.
Ogata Y; Chohnan S
J Gen Appl Microbiol; 2015; 61(6):266-9. PubMed ID: 26782658
[No Abstract] [Full Text] [Related]
10. The coenzyme A biosynthetic pathway: A new tool for prodrug bioactivation.
Duncan D; Auclair K
Arch Biochem Biophys; 2019 Sep; 672():108069. PubMed ID: 31404525
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a new pantothenate kinase isoform from Helicobacter pylori.
Brand LA; Strauss E
J Biol Chem; 2005 May; 280(21):20185-8. PubMed ID: 15795230
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity analysis of CJ-15,801 analogues that interact with Plasmodium falciparum pantothenate kinase and inhibit parasite proliferation.
Spry C; Sewell AL; Hering Y; Villa MVJ; Weber J; Hobson SJ; Harnor SJ; Gul S; Marquez R; Saliba KJ
Eur J Med Chem; 2018 Jan; 143():1139-1147. PubMed ID: 29233590
[TBL] [Abstract][Full Text] [Related]
13. The antibiotic CJ-15,801 is an antimetabolite that hijacks and then inhibits CoA biosynthesis.
van der Westhuyzen R; Hammons JC; Meier JL; Dahesh S; Moolman WJ; Pelly SC; Nizet V; Burkart MD; Strauss E
Chem Biol; 2012 May; 19(5):559-71. PubMed ID: 22633408
[TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial Mode of Action of Pantothenamides: Pantothenate Kinase Serves as a Metabolic Activator Not as a Target.
de Villiers M; Spry C; Macuamule CJ; Barnard L; Wells G; Saliba KJ; Strauss E
ACS Infect Dis; 2017 Jul; 3(7):527-541. PubMed ID: 28437604
[TBL] [Abstract][Full Text] [Related]
15. One-pot chemoenzymatic preparation of coenzyme A analogues.
Nazi I; Koteva KP; Wright GD
Anal Biochem; 2004 Jan; 324(1):100-5. PubMed ID: 14654051
[TBL] [Abstract][Full Text] [Related]
16. Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated.
Spry C; Macuamule C; Lin Z; Virga KG; Lee RE; Strauss E; Saliba KJ
PLoS One; 2013; 8(2):e54974. PubMed ID: 23405100
[TBL] [Abstract][Full Text] [Related]
17. Role of prokaryotic type I and III pantothenate kinases in the coenzyme A biosynthetic pathway of Bacillus subtilis.
Ogata Y; Katoh H; Asayama M; Chohnan S
Can J Microbiol; 2014 May; 60(5):297-305. PubMed ID: 24784177
[TBL] [Abstract][Full Text] [Related]
18. A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites.
Spry C; Chai CL; Kirk K; Saliba KJ
Antimicrob Agents Chemother; 2005 Nov; 49(11):4649-57. PubMed ID: 16251308
[TBL] [Abstract][Full Text] [Related]
19. Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy.
Zano SP; Pate C; Frank M; Rock CO; Jackowski S
Mol Genet Metab; 2015 Dec; 116(4):281-8. PubMed ID: 26549575
[TBL] [Abstract][Full Text] [Related]
20. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
